Variant | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AF EXOME | AF GENOME | Disease | Disease Class | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
1.000 | 0.120 | 8 | 133133268 | intron variant | G/A | snv | 0.49 |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.810 | 1.000 | 2 | 2013 | 2019 | |||||||
|
1.000 | 0.040 | 8 | 132967797 | missense variant | G/A | snv |
|
Endocrine System Diseases | 0.800 | 1.000 | 6 | 1999 | 2016 | ||||||||
|
1.000 | 0.040 | 8 | 133022121 | missense variant | G/A | snv | 4.0E-06 |
|
Endocrine System Diseases | 0.800 | 1.000 | 6 | 1999 | 2016 | |||||||
|
1.000 | 0.040 | 8 | 133029907 | missense variant | G/A | snv | 2.0E-05 | 2.8E-05 |
|
Endocrine System Diseases | 0.800 | 1.000 | 6 | 1999 | 2016 | ||||||
|
0.827 | 0.200 | 8 | 132971804 | missense variant | T/A | snv |
|
Endocrine System Diseases | 0.800 | 1.000 | 6 | 1999 | 2016 | ||||||||
|
1.000 | 0.040 | 8 | 132917672 | intron variant | C/T | snv | 0.41 |
|
Skin and Connective Tissue Diseases | 0.800 | 1.000 | 1 | 2012 | 2012 | |||||||
|
0.925 | 0.040 | 8 | 132882609 | stop gained | C/T | snv | 3.6E-04 | 4.0E-04 |
|
Endocrine System Diseases | 0.700 | 1.000 | 6 | 1999 | 2013 | ||||||
|
0.807 | 0.200 | 8 | 132906843 | missense variant | T/C | snv | 1.6E-05 | 7.0E-06 |
|
Endocrine System Diseases | 0.700 | 1.000 | 6 | 1999 | 2016 | ||||||
|
0.851 | 0.160 | 8 | 133017916 | missense variant | C/A | snv | 4.4E-05 | 2.8E-05 |
|
Endocrine System Diseases | 0.700 | 1.000 | 6 | 1999 | 2016 | ||||||
|
8 | 133120266 | intron variant | G/A | snv | 0.23 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
0.925 | 0.040 | 8 | 132882609 | stop gained | C/T | snv | 3.6E-04 | 4.0E-04 |
|
Endocrine System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
|
1.000 | 8 | 132886447 | splice acceptor variant | G/C | snv | 4.0E-06 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | |||||||||
|
1.000 | 0.040 | 8 | 132906524 | intron variant | A/G | snv | 0.76 |
|
Endocrine System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | |||||||
|
1.000 | 0.040 | 8 | 132918810 | intron variant | A/T | snv | 0.41 |
|
Skin and Connective Tissue Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | |||||||
|
8 | 133074620 | intron variant | T/A | snv | 0.24 |
|
0.700 | 1.000 | 1 | 2018 | 2018 | ||||||||||
|
1.000 | 0.120 | 8 | 133075205 | intron variant | A/G | snv | 0.43 |
|
Eye Diseases; Immune System Diseases; Endocrine System Diseases | 0.700 | 1.000 | 1 | 2013 | 2013 | |||||||
|
8 | 133091709 | intron variant | C/T | snv | 0.41 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
1.000 | 0.040 | 8 | 132873226 | splice region variant | G/A | snv | 2.4E-05 | 1.4E-05 |
|
Endocrine System Diseases | 0.700 | 1.000 | 1 | 2016 | 2016 | ||||||
|
8 | 132904554 | intron variant | G/A | snv | 5.4E-02 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||||
|
8 | 132904554 | intron variant | G/A | snv | 5.4E-02 |
|
Behavior and Behavior Mechanisms | 0.700 | 1.000 | 1 | 2015 | 2015 | |||||||||
|
8 | 132894539 | intron variant | G/A | snv | 0.43 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||||
|
0.882 | 8 | 132926377 | intron variant | C/T | snv | 0.67 |
|
Immune System Diseases | 0.700 | 1.000 | 1 | 2019 | 2019 | ||||||||
|
0.882 | 8 | 132926377 | intron variant | C/T | snv | 0.67 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.882 | 8 | 132926377 | intron variant | C/T | snv | 0.67 |
|
0.700 | 1.000 | 1 | 2019 | 2019 | |||||||||
|
0.882 | 8 | 132926377 | intron variant | C/T | snv | 0.67 |
|
0.700 | 1.000 | 1 | 2019 | 2019 |